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Pransvenous Cryothermal Catheter
blation of Re-Entry Circuit Located Near
he Atrioventricular Junction in Pediatric Patients
fficacy, Safety, and Midterm Follow-Up
abrizio Drago, MD, Antonella De Santis, MD Giorgia Grutter, MD, Massimo S. Silvetti, MD
ome, Italy
OBJECTIVES We investigated the safety and efficacy of cryoablation in the treatment of pediatric patients
with accessory pathways (APs) located near the atrioventricular junction and with atrioven-
tricular nodal re-entrant tachycardia (AVNRT).
BACKGROUND Few studies concern cryoablation in a significant number of pediatric patients involving
treatment for supraventricular tachycardias (SVTs) with the reentry circuit located near the
atrioventricular junction.
METHODS Twenty-six pediatric patients (age range: 5 to 20 years) were treated; 14 had AVNRT, 10 had
Wolff-Parkinson-White syndrome, and 2 had re-entrant SVT due to a concealed AP.
Electrophysiologic study was performed with diagnostic catheters, and cryoablations were
performed with a 7-F 4-mm-tip catheter (Freezor, CryoCath Technologies Inc., Kirkland,
Canada). Cryomapping, used to identify the tissue site for safe arrhythmia ablation, was
performed at 30°C for a maximum of 60 s. Cryoablations were from 4 to 8 min long at
75°C. Acute end points were noninducibility of AVNRT by programmed atrial stimulation
at baseline or during isoproterenol performed 30 min after procedure, as well as noninduc-
ibility and conduction block over the AP. The chronic end point was arrhythmia recurrence
after intervention.
RESULTS No permanent cryo-related complications or adverse outcomes were reported. Twenty-four
(92%) patients were acutely successful. During follow-up (range: 1 to 22 months), seven
(29%) acutely successful pediatric patients experienced arrhythmia recurrence.
CONCLUSIONS Acute results demonstrate cryoablation of SVTs with the reentry circuit located near the
atrioventricular junction to be safe and efficacious in pediatric patients. However, the etiology
of recurrences reported after intervention need further investigation. (J Am Coll Cardiol
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.12.0482005;45:1096–103) © 2005 by the American College of Cardiology Foundation
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iadiofrequency (RF) ablation for treatment of supraventric-
lar tachycardias (SVTs) in pediatric patients was intro-
uced into clinical practice in the late 1980s (1). Since then,
F ablation has evolved into the treatment of choice for
any different tachyarrhythmias in young patients (1–8).
owever, despite the success of RF ablation, there are
eported safety and efficacy concerns that have been raised.
ost notably, RF ablation treatment for patients with
trioventricular nodal re-entrant tachycardia (AVNRT),
olff-Parkinson-White (WPW) syndrome, and other
VTs carries a definite risk for atrioventricular (AV) block
ecause lesion creation within the region of the septum is
lose to the AV node or His bundle (6,9,10). Also, RF
atheter ablation of septal accessory pathways (APs) has
een identified as technically challenging in children due to
he setting of small cardiac dimensions (3). Acute success
ates for RF ablation of various SVTs in pediatric patients
ave been reported to be between 82% and 100% (4,11–14),
nd recurrence rates are between 0% and 14% (3,4,11). The
isk rate of AV block in RF ablation of APs close to the AV
unction or AVNRT in pediatric patients has been reported
From the Department of Pediatric Cardiology, Bambino Gesù Hospital, Rome,
taly.s
Manuscript received September 22, 2004; revised manuscript received November
9, 2004, accepted December 2, 2004.o be between 1.6% and 3% (3,9). Hence, there is a drive to
nvestigate alternative types of ablation energies that are
qually or more efficacious than RF, but safer (15). This is
specially so in pediatric patients undergoing ablation treat-
ent given the medical and quality-of-life consequences of
ermanent AV block. The first report of transvenous
ryoablation was in the early 90s (16), and it was not soon
fter such preclinical studies that trials involving humans
ere conducted.
Preclinical and clinical studies have suggested that cryo
nergy has potential advantages over RF energy for catheter
blation (10,17–20). Some of the identified benefits of cryo
nclude reversibility of conduction block, catheter stability,
nd less procedural discomfort for the patient (20). The
eversibility of conduction block in particular, via a tech-
ique known as cryomapping, is an especially useful safety
enefit of cryo in clinical practice. Cryomapping allows for
he evaluation of the acute effects of cryo on the structures
o be ablated before creating a permanent lesion (21,22).
his is probably the principal reason why no incidence of
ermanent AV block has yet been reported among the many
ryo catheter ablation procedures that have been performed
n the adult population (10,20,22–25).
Despite the weight of evidence from adult patients, theafety and efficacy of cryo catheter ablation for treatment of
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April 5, 2005:1096–103 Cryoablation in Pediatric Patientspecific arrhythmias has only been investigated in a handful
f pediatric patients (26). To our knowledge, there are few
tudies that have investigated cryo catheter ablation treat-
ent of SVTs in a significant number of pediatric patients
ver a reasonably long follow-up period (e.g., six-month
ollow-up and beyond). This study sought to investigate the
afety and efficacy of percutaneous cryothermal ablation in
he treatment of pediatric patients with AVNRT and APs
ocated near the AV junction.
ETHODS
atients. The study population consisted of 26 consecutive
atients who were selected for cryoablation treatment in our
nstitution in the period between August 2002 and April
004. The selected patients either had AVNRT or an AP
ocated near the AV junction. The local ethics committee
pproved the protocol, and informed consent was obtained
rom all patients or their parents before the procedure.
here were 14 patients with AVNRT, 10 patients with
PW syndrome, and 2 patients with a re-entrant SVT due
o a concealed AP. Previous RF ablation was apparent in
ne patient with AVNRT and three patients with WPW
yndrome. The one patient with AVNRT had unsuccessful
F ablation three years before their cryoablation procedure,
nd after the failed RF ablation had received flecainide and
ropranolol. The three patients with WPW had unsuccess-
ul RF ablation about one year before their cryoablation
rocedure. Specifically, the RF ablation procedures in two
f these three WPW patients, one an right anteroseptal AP
atient and the other a mid-septal AP patient, were inter-
upted because of the risk of AV block due to the fact that
he RF ablation catheter was too close to the bundle of His,
fter the occurrence of a fast junctional rhythm during RF
nergy delivery. Antiarrhythmic drugs were stopped five
alf-lives before the cryoablation procedure.
ryoablation system. The cryoablation system consists of a
entral console (Cryo Console, CryoCath Technologies Inc.,
irkland, Canada) and a steerable 7-F catheter (Freezor,
ryoCath Technologies Inc., Kirkland, Canada) with a
-mm-tip electrode using N2O as refrigerant fluid. The
ryoablation system has been previously described elsewhere
22).
ryomapping. Cryomapping (also referred to as ice map-
ing) was performed by progressive reduction in the tip
Abbreviations and Acronyms
AP  accessory pathway
AV  atrioventricular
AVNRT  atrioventricular nodal re-entrant tachycardia
EPS  electrophysiologic study
RF  radiofrequency
SVT  supraventricular tachycardia
WPW  Wolff-Parkinson-Whiteemperature to 30°C for a maximum time of 60 s. This paused transient and reversible loss of electrical function at
he target site and enabled the acute effects of cryo at a site
o be analyzed before the creation of a permanent lesion.
hen cryomapping was positive (e.g., disappearance or
odification of conduction was demonstrated through the
low pathway with no re-induction of tachyarrhythmia
nd disappearance of ventricular pre-excitation) (Fig. 1),
hen the tip temperature was decreased further to create
permanent lesion. When cryomapping produced un-
anted effects (e.g., transient AV block or lengthening of
he PR interval by 50%), cryoapplication was stopped
o allow tissue rewarming and reversibility of the loss in
lectrical function. Subsequently, the cryo catheter was
epositioned to a new target site, and cryomapping was
epeated.
ryoablation. Ablation was performed by cooling the
issue temperature to 75°C. Freezing was maintained at
he lowest attainable temperature for a minimum of 4
in to a maximum of 8 min to create a permanent lesion.
here was one patient who had cryo energy delivery for
nly 2 min; the rationale for this deviation from the
inimum requirement is explained in the Results section.
uring cryoablation, surface electrocardiogram (ECG)
nd endocavitary signals were continuously monitored. If
onduction recurrence or arrhythmia induction were
pparent, the catheter was repositioned at an adjacent
ite, and cryomapping was repeated.
blation procedure for AVNRT. The procedure was
erformed under general anesthesia induced with sevoflu-
ane and propofol and maintained with sevoflurane or
soflurane. A thermal mattress was used to maintain normal
ody temperature. A standard electrophysiologic study
EPS) was conducted before the procedure to confirm the
rrhythmia diagnosis and after the procedure to test the
nducibility of the SVT. Quadripolar catheters were posi-
ioned in the His bundle region and in the right atrium via
he right femoral vein, and a multipolar catheter was
ositioned in the coronary sinus via the left subclavian vein.
urface ECG leads and endocardial potentials were re-
orded and stored on a multichannel recorder (Bard System,
illerica, Massachusetts). Cryoablation was performed in
atients with both: 1) an A-H jump clearly diagnostic of
ual AV nodal physiology (defined as a sudden prolongation
f the A-H interval by 50 ms or greater when shortening the
ycle length of atrial pacing or the coupling interval of the
trial extrastimulus by 10 ms); and 2) inducible AVNRT
isoproterenol infusion [0.01 to 0.04 g/kg/min with incre-
ental steps]). If the A-H jump alone was apparent in a
atient, then the ablation was not performed. After confir-
ation of the diagnosis and following the determination of
reproducible protocol for AVNRT induction, the cryo
atheter was inserted through the right femoral vein and
irected toward the myocardium. A slow pathway ablation
as performed using either an electrogram-guided ap-
roach, with mapping of the slow potential or the sharp
F
a
1098 Drago et al. JACC Vol. 45, No. 7, 2005
Cryoablation in Pediatric Patients April 5, 2005:1096–103igure 1. (A) Cryomapping electrogram of a patient with an anterior septal accessory pathway. (B) Postcryoablation electrogram of a patient with an
nterior septal accessory pathway. RAO  right anterior oblique.
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April 5, 2005:1096–103 Cryoablation in Pediatric Patientsotential, or an anatomic-guided approach. After the cryo
atheter was positioned at the target site, localized on the
asis of the electrophysiological or anatomic approach,
ryomapping was started and atrial extrastimulus testing was
erformed once a temperature of 30°C was reached for at
east 20 s. The efficacy of the cryomapping procedure was
ssessed in terms of disappearance in dual AV node physi-
logy and noninducibility of AVNRT. When cryomapping
as negative, the catheter was repositioned to a new target
ite, and the procedure was repeated. When cryomapping
as positive for the target site, the temperature was reduced
o 75°C for 4 to 8 min to create an irreversible lesion. In
eneral, a 4-min cryoapplication duration was used to create
ryo lesions. Initial selection of this length of exposure to
ryo energy was based on various sources (e.g., evidence
rom preclinical and clinical studies of cryoablation)
18,22,27,28), increasing investigator experience with cryo
n pediatric patients, and review of personal communica-
ions from other investigators who had attempted to assess
he relationship between duration of exposure to cryo energy
nd lesion size. In the present study, there were cases where the
uration of exposure to cryo was beyond 4 min; this was due
o the investigator opting to use a longer cryo application
ime given results from earlier cases that suggested possible
ecurrence after procedure. The ablation procedure was
onsidered successful if AVNRT was noninducible by the
rogrammed atrial stimulation protocol after ablation, ei-
her before or during isoproterenol infusion performed 30
in later.
blation procedure of APs. Two patient groups were
onsidered—those with manifest ventricular preexcitation
nd those with concealed APs. In patients with manifest
entricular preexcitation, the site of earliest ventricular
ctivation was identified during sinus rhythm. It was char-
cterized by a short local AV interval, with local activation
receding the onset of the delta wave on the surface ECG.
fter identification of the possible ablation site, cryomap-
ing was performed, and, if there was a sudden loss of
entricular preexcitation, it was followed by creation of a
ermanent lesion (Fig. 1). In patients with concealed APs,
he parahissian area was carefully mapped during AV
e-entrant tachycardia, and the site of earliest retrograde
trial activation was localized. Cryomapping was performed
t this site and, if successful, as indicated by interruption of
achycardia in the retrograde limb with no modification of
V conduction parameters, was followed by permanent
esion formation. A postablation EPS was performed im-
ediately in all cases, and then repeated 30 min later to
emonstrate normal AV node conduction as well as confirm
omplete and persistent interruption of the conduction over
he AP and noninducibility of the arrhythmia.
ostablation assessment. An echocardiography was per-
ormed 24 h after procedure on all patients. In addition,
atients had a physical exam and ECG before discharge. tESULTS
emographics, patient diagnoses, and EP study charac-
eristics. The mean  SD age of patients was 13.2  3.6
ears. The distribution of males to females involved in this
tudy was 14 to 12.
Of the 26 patients, 14 (54%) had AVNRT, 10 (38%) had
PW syndrome, and 2 (8%) had a concealed AP. All 14
atients with AVNRT had dual AV nodal physiology and a
eproducible inducible AVNRT. Inducibility was demon-
trated in 2 (14%) of 14 patients with AVNRT at baseline,
nd in 12 (86%) of 14 patients during isoproterenol infusion
lone. One (4%) patient had previous ductus arteriosus, two
8%) had a patent foramen ovale, and four (15%) had
revious RF ablation.
In all cases, cryomapping was performed during fixed
verdrive pacing or atrial extrastimulus testing with a
oupling interval critical for AVNRT induction and/or slow
athway conduction. In the other patients, the EPS revealed
he presence of a concealed AP in the right anteroseptal
egion in two patients, as well as a right manifest AP in the
nteroseptal region in five patients, in the midseptal region
n four patients, and in the posterior region in one patient.
n those patients with a concealed AP, an SVT was induced
n one case at baseline and in the other during isoproterenol
nfusion.
cute success—safety and efficacy. There was only one
atient with AVNRT who had transient first-degree AV
lock. This event occurred during the cryomapping step of
he procedure. This transient conduction disturbance dis-
ppeared immediately during defrost, and there were no
urther conduction disturbances noted. During the actual
ryoablation step of the procedure in this patient, a single
ryoapplication was delivered, very close to the site where
he transient complication with cryomapping had occurred,
o create a permanent cryolesion. Although acute success
as achieved in this patient, follow-up assessment indicated
ecurrence of AVNRT eight months after the procedure.
o other complications were reported in any patient.
pecifically, no pericardial effusion or thrombotic formation
as observed with echocardiography performed 24 h after
rocedure.
Cryoablation was successfully performed at intervention
n 24 (92%) of 26 patients. A total of 13 (93%) of 14
atients with AVNRT, 10 (100%) of 10 patients with
PW syndrome, and 1 (50%) of 2 patients with a con-
ealed AP experienced acute success with cryo. In one
atient who underwent a successful ablation of a right
idseptal manifest AP, two other SVTs, due to different
oncealed APs in the anteroseptal and anterior region,
emained inducible; successful ablation of these two APs
as achieved. There were no echoes or slow pathway
onduction after ablation; any AVNRT or single echo was
liminated during the procedure.
There were no patients who crossed over from cryoabla-ion to RF ablation. The one AVNRT patient who expe-
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Cryoablation in Pediatric Patients April 5, 2005:1096–103ienced acute failure with cryo went on to receive oral
herapy with flecainide (5 mg/kg) and was successful on this
edication; this patient had previously failed on this anti-
rrhythmic medication before ablation. The patient with a
oncealed AP who experienced acute failure recently under-
ent a second cryoablation that was an acute success. Unlike
he point of entry used in this cohort of 26 patients, for the
econd cryoablation, the catheter was introduced into the
ubclavian vein (reportedly giving more catheter stability),
nd the duration of cryoapplication for permanent cryole-
ion formation was only 2 min. This less than standard
ryoapplication duration was utilized because the target site
ielded an excellent His bundle electrogram that was clearly
isible after the SVT interruption.
rocedure characteristics. A single cryoapplication was
elivered in 10 patients (4 with AVNRT, 5 with WPW
yndrome, and 1 with a concealed AP); 2 cryoapplications
ere delivered in 6 patients; 3 or more cryoapplications were
elivered in 10 patients. Cryoapplications were delivered
ith a mean temperature of 74  1.8°C for a mean
uration of 5.7  1.5 min. The mean number of cryoabla-
ions and fluoroscopy time was 3  2 and 38.7  21.4 min,
espectively. The mean fluoroscopy times for patients with
VNRT, WPW syndrome, and concealed APs were 33.8
13.1 min, 38.8  24.8 min, and 61.3  29.9 min,
espectively.
A couple of notable observations were made during our
xperience with cryoablation in these 26 pediatric patients.
junctional rhythm did not develop in any treated patient.
owever, in one patient with AVNRT, a transient length-
ning of AV conduction was observed during a second
ryoablation in the midseptal area; it occurred 120 s after a
emperature of 75°C was reached. Consequently, cryoab-
ation was stopped, and a complete recovery of the AV
nterval subsequently ensued after tissue rewarming. More-
ver, the SVT was no longer inducible in this patient. No
ther patients experienced significant modification of the
-H interval while in sinus rhythm, either at baseline or
uring isoproterenol infusion at the end of the procedure. In
ther cases (one patient with a right midseptal WPW and
ne patient with AVNRT) only a maximum temperature of
able 1. Electrophysiological and Ablation Characteristics Associ
ith Cryo at Intervention
Parameters
ype of arrhythmia, n
revious RF ablation, n (%)
ryomapping temperature (°C), mean  SD; range
ryoablations, mean  SD; range
ryoablation temp (°C), mean  SD; range
uration of cryoablation temp (min), mean  SD; range
rocedure time (min), mean  SD
luoroscopy time (min), mean  SD
P  accessory pathway; AVNRT  atrioventricular nodal re-entrant tachycardia;70°C was reached; this phenomenon was probably due to
a
fin excessive blood re-warming effect. Although both these
atients were acute successes with only one and two cryoap-
lications delivered to each, respectively, both patients
xperienced arrhythmia recurrence during the follow-up
eriod.
The electrophysiological and ablation characteristics as-
ociated with patients who were acute successes or failures
ith cryo at intervention are shown in Table 1.
ong-term success—follow-up outcomes. No patients
ere lost to follow-up. During follow-up (range: 1 to 22
onths), 7 (29%) of 24 patients who were acutely successful
ad arrhythmia recurrence. A Kaplan-Meier curve (Fig. 2)
hows the cumulative proportion of the 24 acutely successful
atients who were without arrhythmia recurrence up to 12
onths’ follow-up. There were five patients who had
CG-documented arrhythmia recurrence, whereas two pa-
ients had recurrence documented in patient diary records.
With Those Patients Who Were Acute Successes or Failures
Acute Success
(n  24)
Acute Failure
(n  2)
AVNRT; 1 concealed AP;
10 WPW syndrome
1 AVNRT; 1 concealed AP
4 (17%) 0 (0%)
30  2; 27 to 40 30  0
2  2; 1 to 9 5  2; 3 to 6
74  2; 70 to 76 75  0
6  2; 2 to 8 5  1; 4 to 5
243  71; 115 to 460 342  88; 280 to 405
36  18; 15 to 100 77  25; 59 to 95
radiofrequency; WPW  Wolff-Parkinson-White.
igure 2. Kaplan-Meier curve showing the cumulative proportion ofated
13cutely successful patients without arrhythmia recurrence reported up to a
xed time point of 12 months follow-up.
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April 5, 2005:1096–103 Cryoablation in Pediatric Patientsmong those patients with AVNRT, one patient experi-
nced recurrence at two months after intervention while
nother patient was recurrent at eight months after proce-
ure. All recurrent patients with WPW syndrome experi-
nced recurrence within one month of intervention. Neither
f the two patients with concealed APs, one of whom was
n acute failure with cryo but received a second successful
blation, experienced arrhythmia recurrence during the
ollow-up period.
A combination of warmer than average temperatures and
ower than average number of cryoapplication deliveries to
he target site may have played a role in the arrhythmia not
eing permanently eradicated in recurrent patients. The
verage age of recurrent and recurrence-free patients was
2.7  4.3 years and 13.7  3.5 years, respectively. Hence,
ifferences in sensitivity to cryotherapy of younger myocar-
ial cells were an unlikely factor determining recurrence in
his group of patients.
The electrophysiologic and ablation characteristics asso-
iated with those acutely successful patients who either did
r did not experience arrhythmia recurrence during
ollow-up are shown in Table 2.
ISCUSSION
his study documents the use of a 7-F 4-mm-tip cryoab-
ation catheter for treatment of pediatric patients with SVTs
ue to AVNRT and manifest or concealed APs located near
he AV junction. There were no permanent cryo-related
omplications or adverse outcomes reported at intervention
r during follow-up. There was no incidence of permanent
V block. Twenty-four (92%) patients were acutely suc-
essful. During follow-up (range: 1 to 22 months), seven
29%) acutely successful pediatric patients experienced ar-
hythmia recurrence. Arrhythmia recurrence was identified
n three patients within 24 h of the procedure, in one patient
ithin the first month of follow-up, in one patient within
he sixth months of follow-up, and two patients within the
rst year of follow-up. The outcome for these seven patients
able 2. Electrophysiological and Ablation Characteristics Associ
id Not Experience Arrhythmia Recurrence During Follow-Up*
Parameters
ype of arrhythmia, n (%)
revious RF ablation, n (%)
ryomapping temp (°C), mean  SD; range
ryoablations, mean  SD; range
ryoablation temp (°C), mean  SD; range
uration of cryoablation temp (min), mean  SD; range
rocedure time (min), mean  SD
luoroscopy time (min), mean  SD
Although 2 of 26 patients were acute failures, one of these acute failure patients rec
here were 25 acutely successful patients who were monitored for arrhythmia recurre
Abbreviations as in Table 1.ho had arrhythmia recurrence is that one patient with rVNRT was subsequently ablated with RF; one patient
ith a posterior septal AP was subsequently ablated with
F; one patient with AVNRT is presently on drug therapy
ue to frequent recurrences being experienced; three pa-
ients (two with anteroseptal AP and one with midseptal
P) are off drug therapy because they have not experienced
ecurrences despite the occurrence of ventricular preexcita-
ion; one patient with AVNRT is off drug therapy because
nly brief, sporadic, and non-documented palpitations are
xperienced.
Although the results of the present study demonstrate an
xcellent safety and acute success profile for cryoablation in
he treatment of SVTs in which the reentry circuit is located
ear the AV junction in a pediatric population, the number
f arrhythmia recurrences during the long follow-up period
equires explanation. An attempt at addressing this issue has
een made by assessing the electrophysiological and ablation
haracteristics associated with patients who were acute
ailures as well as those acutely successful patients who later
xperienced arrhythmia recurrence (Tables 1 and 2). Al-
hough difficulties were anticipated due to scar tissue caused
y previous RF ablation around the target site, results show
hat previous RF ablation does not appear to have a negative
mpact on the acute success of cryo.
Results do show that patients who showed acute failure
ith cryo had over double the number of ablations (5 vs. 2)
nd over twice the fluoroscopy time (77 min vs. 36 min)
han those who experienced acute success with cryo. These
ncreases may point toward acute failure cases being partic-
larly difficult arrhythmias to localize and then penetrate
ith deep and wide permanent lesions. Apart from the
ifference in ablation temperatures, there appears to be no
pecific electrophysiological or ablation characteristics that
xplain the arrhythmia recurrences (Table 2). Certain pa-
ients who had arrhythmia recurrence may not have been
xposed to cryoablation temperatures for the minimum time
eriod required. The time range of exposure to cryoablation
emperatures among the seven patients who had arrhythmia
With Those Acutely Successful Patients Who Either Did or
No Recurrence
During Follow-Up
(n  18)
Recurrence
During Follow-Up
(n  7)
NRT; 2 concealed APs;
6 WPW syndrome
3 AVNRT; 4 WPW syndrome
4 (22%) 0 (0%)
30  1; 27 to 30 31  4; 30 to 40
3  2; 1 to 6 3  2; 1 to 6
74  2; 70 to 75 74  2; 71 to 77
6  1; 4 to 8 6  2; 2 to 8
62  75; 155 to 460 221  73; 115 to 320
43  19; 15 to 95 42  28; 20 to 100
a second successful cryoablation. Consequently, at the end of the follow-up period,ated
10 AV


2
eived
nce.ecurrence was 2 to 8 min, as opposed to the required 4 to
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Cryoablation in Pediatric Patients April 5, 2005:1096–103min. The 18 patients who experienced long-term success
ith cryo had a time range of exposure to cryoablation
emperatures of 4 to 8 min. Again, results also showed that
hether patients underwent previous RF ablation did not
ave a negative impact on long-term success.
Elimination of all jumps, echoes, and evidence of slow
athway conduction may not decrease the recurrence rate.
he issue may well be not what must be eliminated to
revent recurrence but rather how much time must be taken
fter an acutely successful cryoablation to be sure that a
hronically successful cryoablation was performed. The
ecurrences arising during long-term follow-up in acutely
uccessful patients may well be due to the targeted tissue
ousing cells that remain in a “hibernated state” after
blation, and with these cells being viable they have the
apacity to resume their arrhythmic activity after ablation.
oreover, the capacity of these hibernating cells to rejuve-
ate after ablation may be greater in pediatric patients than
dult patients. This may explain the higher recurrence rate
eported in this present study versus similar studies in which
dult patients have been treated with cryo.
tudy limitations. This study has limitations. First, this
tudy was not controlled. It was a single arm study with no
andomized comparison to either RF catheter ablation or
ther treatment strategies. Nonetheless, this study ulti-
ately sought to document our experience with a 7-F,
-mm cryo catheter for treatment of SVTs in which the
eentry circuit is located near the AV junction in a pediatric
opulation. Second, this study involved only 26 patients.
espite this, the study population did have a follow-up
eriod of up to 22 months with a low drop-out rate. Third,
rrhythmia recurrence was reported by a combination of
atient diary records as well as ECG-documented recur-
ences, the former of which could be more subject to
isinterpretation and/or reporting errors. Finally, discom-
ort with cryo could not be evaluated in this pediatric
opulation as all patients were under general anesthesia
uring the procedure. Nonetheless, studies in both adult
nd pediatric patients have reported an absence of discom-
ort with cryo energy delivery (20,26).
onclusions. Safety and efficacy of cryoablation treatment
or 26 pediatric patients (age range: 5 to 20 years) with
VTs in which the reentry circuit is located near the AV
unction in the pediatric population was investigated over a
ollow-up period of almost two years. There were no
ryo-related complications or adverse outcomes reported at
ntervention or during follow-up. Twenty-four (92%) pa-
ients were acutely successful with cryo. During follow-up,
even (29%) acutely successful pediatric patients experienced
rrhythmia recurrence. Preliminary investigation of electro-
hysiological and ablation characteristics did not clearly
dentify possible predictors of long-term success or reasons
hy certain patients experienced arrhythmia recurrence over
he lengthy follow-up period. Further investigation of this
ssue is required.cknowledgments
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